Reports for MINT PHARMACEUTICALS INC

Company Name

MINT PHARMACEUTICALS INC

Totals

Shortage reports

64

Actual shortage: 22 (34%)
Anticipated shortage: 1 (2%)
Avoided shortage: 0 (0%)
Resolved: 41 (64%)

Discontinuation Reports

13

To be discontinued: 0 (0%)
Discontinued: 13 (100%)
Reversed: 0 (0%)

Late reports

8 (10%)

Overdue reports

1 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-SIMVASTATIN 80MG TABLET Resolved 2018-01-09 2018-02-15 35489
MINT-SOLIFENACIN 5MG TABLET Resolved 2018-01-09 2018-03-21 35492
MINT-SOLIFENACIN 10MG TABLET Resolved 2018-01-09 2018-03-21 35495
MINT-TOPIRAMATE 100MG TABLET Resolved 2017-11-07 2018-01-04 28570

Showing 61 to 64 of 64

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58283
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58286
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74435
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74442
MINT-DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Discontinued 2019-06-04 2019-06-04 85525
MINT-METFORMIN 500MG TABLET Discontinued 2019-07-04 2019-07-05 88513
MINT-RIVASTIGMINE 3MG CAPSULE Discontinued 2017-06-21 2017-07-01 13556
MINT-RIVASTIGMINE 6MG CAPSULE Discontinued 2017-06-21 2017-07-01 13559
MINT-RIVASTIGMINE 1.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13562
MINT-RIVASTIGMINE 4.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13565
MINT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13544
MINT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13553
MINT-ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13540